Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1980 1
1981 3
1982 8
1983 4
1984 2
1985 1
1986 4
1987 8
1988 1
1989 3
1992 1
1993 3
1994 1
2004 1
2007 2
2010 1
2019 1
2021 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Laskin OL. Laskin OL. Ration Drug Ther. 1984 May;18(5):1-6. Ration Drug Ther. 1984. PMID: 6096924 No abstract available.
Clinical pharmacokinetics of acyclovir.
Laskin OL. Laskin OL. Clin Pharmacokinet. 1983 May-Jun;8(3):187-201. doi: 10.2165/00003088-198308030-00001. Clin Pharmacokinet. 1983. PMID: 6342900 Review. No abstract available.
Clinical pharmacokinetics of thalidomide.
Teo SK, Colburn WA, Tracewell WG, Kook KA, Stirling DI, Jaworsky MS, Scheffler MA, Thomas SD, Laskin OL. Teo SK, et al. Among authors: laskin ol. Clin Pharmacokinet. 2004;43(5):311-27. doi: 10.2165/00003088-200443050-00004. Clin Pharmacokinet. 2004. PMID: 15080764 Review.
Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects.
Kong R, Laskin OL, Kaushik D, Jin F, Ma J, McIntosh J, Souza M, Almstead N. Kong R, et al. Among authors: laskin ol. Clin Pharmacol Drug Dev. 2019 Feb;8(2):172-178. doi: 10.1002/cpdd.645. Epub 2019 Jan 10. Clin Pharmacol Drug Dev. 2019. PMID: 30629861 Free PMC article. Clinical Trial.
Acyclovir prophylaxis of herpes-simplex-virus infections.
Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS. Saral R, et al. Among authors: laskin ol. N Engl J Med. 1981 Jul 9;305(2):63-7. doi: 10.1056/NEJM198107093050202. N Engl J Med. 1981. PMID: 6264292 Clinical Trial.
Preclinical and Early Clinical Development of PTC596, a Novel Small-Molecule Tubulin-Binding Agent.
Jernigan F, Branstrom A, Baird JD, Cao L, Dali M, Furia B, Kim MJ, O'Keefe K, Kong R, Laskin OL, Colacino JM, Pykett M, Mollin A, Sheedy J, Dumble M, Moon YC, Sheridan R, Mühlethaler T, Spiegel RJ, Prota AE, Steinmetz MO, Weetall M. Jernigan F, et al. Among authors: laskin ol. Mol Cancer Ther. 2021 Oct;20(10):1846-1857. doi: 10.1158/1535-7163.MCT-20-0774. Epub 2021 Jul 26. Mol Cancer Ther. 2021. PMID: 34315764 Free PMC article. Clinical Trial.
Disposition of intravenous radioactive acyclovir.
de Miranda P, Good SS, Laskin OL, Krasny HC, Connor JD, Lietman PS. de Miranda P, et al. Among authors: laskin ol. Clin Pharmacol Ther. 1981 Nov;30(5):662-72. doi: 10.1038/clpt.1981.218. Clin Pharmacol Ther. 1981. PMID: 7297024
Pharmacokinetics and Safety of PTC596, a Novel Tubulin-Binding Agent, in Subjects With Advanced Solid Tumors.
Shapiro GI, O'Mara E, Laskin OL, Gao L, Baird JD, Spiegel RJ, Kaushik D, Weetall M, Colacino J, O'Keefe K, Branstrom A, Goodwin E, Infante J, Bedard PL, Kong R. Shapiro GI, et al. Among authors: laskin ol. Clin Pharmacol Drug Dev. 2021 Aug;10(8):940-949. doi: 10.1002/cpdd.904. Epub 2021 Jan 13. Clin Pharmacol Drug Dev. 2021. PMID: 33440067 Clinical Trial.
52 results